Virtual Radiologic Corporation has completed the deployment of vRad® PACS, its proprietary picture communications and archiving system for radiologic case processing. Replacing previously used commercial software, vRad PACS is now being used by all of the Company’s 140 affiliated radiologists to perform clinical interpretations on radiologic cases transmitted in real-time from over 7,400 different image sending devices located at more than 1,150 medical facilities across the United States.

For the full story, Click Here

Medisch Spectrum Twente Hospital (MST) researchers have developed several quantitative EEG techniques for the purposes of EEG monitoring, one of them being the Brain Symmetry Index. BSI extracts the essential data from an EEG and converts it into a clear signal, or even into written text. An initial prototype is already undergoing evaluation in an intensive care setting. Further development will take place in close collaboration with MST and the University Medical Centre in Nijmegen.

For the full story, Click Here

XenoPort Inc. and GlaxoSmithKline PLC have said that the FDA needs three more months to review an application to a neuropathic pain drug being developed by them. The FDA should complete its review of the drug, called gabapentin enacarbil, by Feb. 9, 2010 said the companies. The FDA wanted the companies to develop a strategy to evaluate the drug’s risks, and after GlaxoSmithKline submitted that strategy, the agency needed additional time to review it.

For the full story, Click Here

Toshiba’s Aquilion® ONE dynamic volume CT system has the ability to improve the quality of life for patients with neurological symptoms, by reducing diagnosis time to minutes. Highlighting these capabilities, Toshiba America Medical Systems, Inc. featured the Aquilion ONE at this year’s Radiological Society of North America (RSNA) annual meeting. The Aquilion ONE allows physicians to reduce diagnosis time for life-threatening conditions such as a stroke from hours or days to minutes.

K2M, Inc. has announced the launch of the TERRA NOVA^® Minimally Invasive Access System and the SERENGETI^® Disposable Kit at the North American Spine Society (NASS) 2009 Annual Conference. TERRA NOVA is a minimally invasive spine-based access system used in conjunction with K2M’s revolutionary SERENGETI percutaneous retractor. TERRA NOVA has the potential to minimize tissue disruption by utilizing a small incision and muscle splitting technique.